Muscular Dystrophy Specialized Research Center

肌营养不良症专业研究中心

基本信息

  • 批准号:
    10652506
  • 负责人:
  • 金额:
    $ 146.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-06-08 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

OVERALL SUMMARY The overall goal of the University of Iowa Wellstone Muscular Dystrophy Specialized Research Center (MDSRC) is to perform research on the various muscular dystrophies that arise from abnormal processing of the dystroglycan protein (dystroglycanopathies). The Center will achieve this overall goal by conducting basic and translational research in dystroglycanopathy patients, patient-derived biosamples, and mouse models. Our MDSRC application is composed of two projects and three cores, all of which are directed by investigators with a proven track record of excellence and collaboration in basic, translational and clinical research. Project 1 (Campbell) will investigate the cellular and molecular mechanisms that underly dystroglycanopathies by evaluating the relationship between α-dystroglycan (α-DG) matriglycan length and its laminin-binding properties in control and dystroglycanopathy patient fibroblasts and muscle biopsies. Additional studies will define the requirements for matriglycan synthesis as regulated by protein-protein and protein-sugar interactions. A dystroglycanopathy mouse model will be utilized to identify novel pathophysiologic mechanisms and determine the structure and laminin binding properties required to improve muscle function. Project 2 (Mathews) will refine the natural history of FKRP-related dystroglycanopathy derived from an established, unique cohort of patients by expanding the number of clinical sites evaluating patients and by extending the natural history study to patients with more advanced clinical severity. Extended follow up of non-FKRP genotypes will identify cohorts that share similar rates of motor progression who might be studied together in gene non-specific clinical trials. Candidate proteomic biomarkers in blood or urine for the full spectrum of dystroglycanopathy genotypes will be validated and related to disease status. Core A (Campbell and Moore) is an administrative core that will coordinate the activities within and outside the Center, as a means to promote an interactive and collaborative research environment, and to engage patients in muscular dystrophy research. Core B (Moore), a Muscle-Tissue/Cell-Culture/Diagnostics Core, will support Projects 1 and 2, serve as a national tissue and cell-culture resource for research, provide specialized diagnostic testing for a wide range of muscular dystrophies, and maintain the infrastructure needed to evaluate muscle biopsies in support of clinical trials. Finally, Core C (Mathews and Campbell) will coordinate our Training initiatives. Among the support this Core provides will be fellowships enabling two medical students per year to perform research in the Center and to participate in the care of patients alongside Dr. Mathews, with basic science training opportunities also provided to a postdoctoral fellow and an undergraduate research fellow. The highly integrated cores and projects of this Center will accelerate the tempo of discovery in preclinical translational research, and also establish the clinical-trial readiness of a cohort of dystroglycanopathy patients.
整体总结

项目成果

期刊论文数量(163)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Large1 gene transfer in older myd mice with severe muscular dystrophy restores muscle function and greatly improves survival.
  • DOI:
    10.1126/sciadv.abn0379
  • 发表时间:
    2022-05-27
  • 期刊:
  • 影响因子:
    13.6
  • 作者:
  • 通讯作者:
Structural basis of laminin binding to the LARGE glycans on dystroglycan.
  • DOI:
    10.1038/nchembio.2146
  • 发表时间:
    2016-10
  • 期刊:
  • 影响因子:
    14.8
  • 作者:
    Briggs DC;Yoshida-Moriguchi T;Zheng T;Venzke D;Anderson ME;Strazzulli A;Moracci M;Yu L;Hohenester E;Campbell KP
  • 通讯作者:
    Campbell KP
Development and Validation of a Western Blot Method to Quantify Mini-Dystrophin in Human Skeletal Muscle Biopsies.
  • DOI:
    10.1208/s12248-022-00776-0
  • 发表时间:
    2022-12-20
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Dystrophin and mini-dystrophin quantification by mass spectrometry in skeletal muscle for gene therapy development in Duchenne muscular dystrophy.
  • DOI:
    10.1038/s41434-021-00300-7
  • 发表时间:
    2022-11
  • 期刊:
  • 影响因子:
    5.1
  • 作者:
    Farrokhi, Vahid;Walsh, Jason;Palandra, Joe;Brodfuehrer, Joanne;Caiazzo, Teresa;Owens, Jane;Binks, Michael;Neelakantan, Srividya;Yong, Florence;Dua, Pinky;Le Guiner, Caroline;Neubert, Hendrik
  • 通讯作者:
    Neubert, Hendrik
Cell surface glycan engineering reveals that matriglycan alone can recapitulate dystroglycan binding and function.
  • DOI:
    10.1038/s41467-022-31205-7
  • 发表时间:
    2022-06-24
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KEVIN P. CAMPBELL其他文献

KEVIN P. CAMPBELL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KEVIN P. CAMPBELL', 18)}}的其他基金

High-throughput genetic & small-molecule screening for therapeutic modifiers
高通量遗传
  • 批准号:
    7853260
  • 财政年份:
    2009
  • 资助金额:
    $ 146.65万
  • 项目类别:
Epsilon-sarcoglycan in LGMD Type 2D
LGMD 2D 型中的 ε-肌聚糖
  • 批准号:
    7836793
  • 财政年份:
    2009
  • 资助金额:
    $ 146.65万
  • 项目类别:
High-throughput genetic & small-molecule screening for therapeutic modifiers
高通量遗传
  • 批准号:
    7938795
  • 财政年份:
    2009
  • 资助金额:
    $ 146.65万
  • 项目类别:
Muscular Dystrophy Specialized Research Center: Project 1
肌营养不良症专业研究中心:项目1
  • 批准号:
    10442635
  • 财政年份:
    2005
  • 资助金额:
    $ 146.65万
  • 项目类别:
Muscular Dystrophy Cooperative Research Center
肌营养不良症合作研究中心
  • 批准号:
    7989616
  • 财政年份:
    2005
  • 资助金额:
    $ 146.65万
  • 项目类别:
Muscular Dystrophy Cooperative Research Center
肌营养不良症合作研究中心
  • 批准号:
    7074057
  • 财政年份:
    2005
  • 资助金额:
    $ 146.65万
  • 项目类别:
CAMPBELL Administrative Core: Muscular Dystrophy Cooperative Research Center
坎贝尔行政核心:肌营养不良症合作研究中心
  • 批准号:
    9108456
  • 财政年份:
    2005
  • 资助金额:
    $ 146.65万
  • 项目类别:
Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10652507
  • 财政年份:
    2005
  • 资助金额:
    $ 146.65万
  • 项目类别:
Muscular Dystrophy Specialized Research Center: Project 1
肌营养不良症专业研究中心:项目1
  • 批准号:
    10652520
  • 财政年份:
    2005
  • 资助金额:
    $ 146.65万
  • 项目类别:
Research Training and Education
研究培训和教育
  • 批准号:
    8377951
  • 财政年份:
    2005
  • 资助金额:
    $ 146.65万
  • 项目类别:

相似海外基金

Advisory Committees
咨询委员会
  • 批准号:
    7353899
  • 财政年份:
    2006
  • 资助金额:
    $ 146.65万
  • 项目类别:
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
  • 批准号:
    0451289
  • 财政年份:
    2005
  • 资助金额:
    $ 146.65万
  • 项目类别:
    Standard Grant
Advisory Committees
咨询委员会
  • 批准号:
    7557224
  • 财政年份:
  • 资助金额:
    $ 146.65万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7902286
  • 财政年份:
  • 资助金额:
    $ 146.65万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7691385
  • 财政年份:
  • 资助金额:
    $ 146.65万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    8150373
  • 财政年份:
  • 资助金额:
    $ 146.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了